Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation

B Burstein, S Nattel - Journal of the American College of Cardiology, 2008 - jacc.org
Atrial Fibrosis Mechanisms and Clinical Relevance in Atrial Fibrillation Brett Burstein,
Stanley Nattel Atrial fibrillation (AF) is the most common arrhythmia in the clinical setting …

Molecular mechanisms of myocardial remodeling

B Swynghedauw - Physiological reviews, 1999 - journals.physiology.org
Swynghedauw, Bernard. Molecular Mechanisms of Myocardial Remodeling. Physiol. Rev.
79: 215–262, 1999.—“Remodeling” implies changes that result in rearrangement of …

Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism

P Milliez, X Girerd, PF Plouin, J Blacher… - Journal of the American …, 2005 - jacc.org
Objectives: The aim of this report was to show that the rate of cardiovascular events is
increased in patients with either subtype of primary aldosteronism (PA). Background …

Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms

S Hein, E Arnon, S Kostin, M Schönburg… - Circulation, 2003 - Am Heart Assoc
Background—The progression of compensated hypertrophy to heart failure (HF) is still
debated. We investigated patients with isolated valvular aortic stenosis and differing …

Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure

B López, R Querejeta, A González, E Sánchez… - Journal of the American …, 2004 - jacc.org
Objectives: This individually randomized, open-label, parallel-group pilot study was
designed to test the hypothesis that the ability of loop diuretics to interfere with cardiac …

Genetics and epigenetics of atrial fibrillation

E Lozano-Velasco, D Franco, A Aranega… - International journal of …, 2020 - mdpi.com
Atrial fibrillation (AF) is known to be the most common supraventricular arrhythmia affecting
up to 1% of the general population. Its prevalence exponentially increases with age and …

Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy

R Patel, SF Nagueh, N Tsybouleva, M Abdellatif… - Circulation, 2001 - Am Heart Assoc
Background Hypertrophic cardiomyopathy is a genetic disease characterized by cardiac
hypertrophy, myocyte disarray, interstitial fibrosis, and left ventricular (LV) dysfunction. We …

Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans

MA Rossi - Journal of hypertension, 1998 - journals.lww.com
Objective To investigate pathologic fibrosis and connective tissue matrix in left ventricular
hypertrophy due to chronic arterial hypertension in humans. Design and methods …

Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin‐diabetic rats

G Miric, C Dallemagne, Z Endre… - British journal of …, 2001 - Wiley Online Library
Fibrosis leads to chronic impairment of cardiac and renal function and thus reversal of
existing fibrosis may improve function and survival. This project has determined whether …

Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic …

N Tsybouleva, L Zhang, S Chen, R Patel, S Lutucuta… - Circulation, 2004 - Am Heart Assoc
Background—Human hypertrophic cardiomyopathy (HCM), the most common cause of
sudden cardiac death in the young, is characterized by cardiac hypertrophy, myocyte …